Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients

Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients

Abstract Background HCV and HIV co-infected patients develop cirrhosis more rapidly than HCV mono-infection. Intestinal injury and microbial translocation are postulated mechanisms for the rapid progression of cirrhosis. Aim Study the effect of HCV treatment with DAAs on serum intestinal fatty acid...

Full description

Bibliographic Details
Main Authors: Hanan Abdelhaleem, Marwa Khairy, Mahmoud Abdo, Ahmed Cordie, Marwa Elsharkawy, Shereen Abdel Alem, Aisha Elsharkawy, Lamiaa Al sehemy, Gamal Esmat
Format: Article
Language:English
Published: SpringerOpen 2023-04-01
Series:Egyptian Liver Journal
Subjects:
I-FABP
HCV/HV co-infection
Hepatic fibrosis
ALT
FIB4
Online Access:https://doi.org/10.1186/s43066-023-00255-x

Internet

https://doi.org/10.1186/s43066-023-00255-x

Similar Items